Developer docs
API playgroundTry for free, no card

Search company profiles

France Oxygène

Full company profile

uuid000oalc

Namestring
France Oxygène
Legal namestring
FRANCE OXYGENE REGION NORD
Company typeenum
Private
Founded yearint
1996
Descriptiontext

France Oxygène is a French home healthcare provider (Prestataire de Santé à Domicile, or PSAD) that has specialized in respiratory assistance since its founding in 1996 in Nord-Pas-de-Calais. The company delivers and maintains medical equipment for oxygen therapy, invasive and non-invasive ventilation, Continuous Positive Airway Pressure (CPAP/PPC) therapy, and aerosol therapy for patients at home, in hospitalization-at-home (HAD) settings, in nursing homes (EHPAD), and at vacation locations. Patients are predominantly individuals with chronic respiratory insufficiency — including COPD, sleep apnea, cystic fibrosis, severe asthma, emphysema, and facial vascular algias — referred by liberal physicians, hospital pulmonologists, and sleep laboratories. The company operates 12 regional agencies across Hauts-de-France, Grand-Est, Normandie, and Bourgogne-Franche-Comté, and is a wholly-owned subsidiary of SOL Group, the 3rd largest European gas provider, which it joined in 2000 to enable cross-border patient continuity.

The core technology stack is medical-device-centric rather than software-centric: France Oxygène deploys, maintains, and monitors respiratory equipment manufactured by Resmed, Philips Respironics, Lowenstein, GCE, Caire, Devilbiss, Breas, and Inogen. The company runs a prescriber portal (Espace Médecin / medecin.franceoxygene.fr) for healthcare-professional coordination, and in 2019 extended its platform with INFUSOL — a dedicated department for perfusion, nutrition, and insulinotherapy — and a VIVITRAVEL service that coordinates respiratory care across Europe through the SOL Group network. Cap'Air adapted physical-activity centers (Coudekerque-Branche and Lens) provide adjunct lifestyle programming for respiratory-insufficiency patients. France Oxygène and InfuSol obtained ISO 9001 certification in 2023.

The business model is a regulated, reimbursement-driven home healthcare service. As a licensed PSAD, France Oxygène is reimbursed by the French Assurance Maladie national health insurance system based on physician prescriptions, with supplementary insurers covering residual amounts; the company manages all administrative procedures on behalf of patients. Revenue is effectively recurring while a patient remains on therapy, with equipment installation, maintenance, consumables, therapeutic education, and 24/7 follow-up bundled into the per-patient tariff. The customer segments are individual chronic patients on the demand side and the national payer plus the prescriber channel on the supply side, creating a B2C/B2B2C GTM anchored on referral-driven acquisition and regulated reimbursement economics rather than direct-to-consumer marketing.

Short descriptiontext

France Oxygène is a French home healthcare provider (PSAD), founded in 1996 and wholly-owned by SOL Group, delivering respiratory assistance — oxygen therapy, ventilation, CPAP, and aerosol therapy — to 75,000+ chronic patients across 12 agencies in Northern, Eastern, and Western France.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersTemplemars, France
HQ citystring
Templemars
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices12 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
home respiratory assistance, oxygen therapy services, home healthcare provider, sleep apnea treatment, ventilation therapy
Industry4 codes
1Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
CodeHLAKANAMPrimaryYes
2Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers)
CodeHSABAKADPrimaryNo
3Home Respiratory & Ventilator Care (Skilled)
CodeHLADAFAIPrimaryNo
4Cardiac & Pulmonary Clinical Home Health (e.g., CHF/COPD)
CodeHSABACAIPrimaryNo
SIC code2 codes
  • Services-Home Health Care Services8082
  • Services-Health Services8000
Product category
Home Healthcare / Respiratory Therapy Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Healthcare Reimbursement
TypeManaged Services
Description

As a French PSAD (Prestataire de Santé à Domicile), France Oxygène operates under the French national health insurance system. Services are reimbursed through the Assurance Maladie system based on prescriptions from physicians. The company manages all administrative procedures with health insurance funds and supplementary insurers.

franceoxygene.fr
2Home Respiratory Assistance
TypeSubscription Recurring
Description

Core revenue stream from providing oxygen therapy, ventilation (invasive and non-invasive), CPAP, and aerosol therapy to patients at home, in nursing homes, or during hospitalization at home.

franceoxygene.fr
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Cap'Air
Description

Club d'Activité Physique Adaptée pour Insuffisants Respiratoires - adapted physical activity centers for respiratory insufficiency patients, located in Coudekerque-Branche and Lens, Hauts-de-France.

franceoxygene.fr
+1 more record
Core offering1 text field

France Oxygène is a French home healthcare provider (Prestataire de Santé à Domicile, PSAD) that installs, maintains, and supports respiratory assistance equipment for patients at home. Its core services cover home oxygen therapy, invasive and non-invasive ventilation, Continuous Positive Airway Pressure (CPAP) for sleep apnea, and aerosol therapy, delivered 24/7 through 12 regional agencies across Northern, Eastern, and Western France under the French national health insurance reimbursement system.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 75,000+ patients cared for at home, in HAD, in EHPAD, and at vacation locations
Product overview1 text field

France Oxygène is a Prestataire de Santé à Domicile (PSAD) offering a comprehensive home healthcare platform centered on respiratory assistance. The core offering combines oxygen therapy, invasive and non-invasive ventilation, CPAP therapy, and aerosol therapy, supported by medical equipment provision from major manufacturers. The company has expanded through INFUSOL (perfusion/nutrition/insulinotherapy, 2019) and VIVITRAVEL (travel assistance), while Cap'Air centers provide adapted physical activity programs. The prescriber portal (Espace Médecin) enables healthcare professional coordination, all supported by 24/7 service and ISO 9001 certification.

Product and service6 records
1Oxygénothérapie à domicile (Home oxygen therapy)
CategoryHome respiratory therapy
Description

Home oxygen therapy service providing supplemental oxygen for patients with respiratory conditions such as COPD, emphysema, cystic fibrosis, and severe asthma who require oxygen support at home. The service includes equipment delivery, installation, and ongoing maintenance.

2Ventilation invasive et non invasive (Invasive and non-invasive ventilation)
CategoryHome respiratory therapy
Description

Respiratory ventilation services covering both invasive and non-invasive ventilation methods for patients requiring breathing assistance at home, including trachéotomie (tracheostomy) support.

3Pression Positive Continue (CPAP) therapy
CategoryHome respiratory therapy
Description

Continuous Positive Airway Pressure (CPAP) therapy for sleep apnea in adults, children, and central apnea cases, including device provision, installation, follow-up, and therapeutic education.

4Aérosolthérapie (Aerosol therapy)
CategoryHome respiratory therapy
Description

Aerosol therapy service providing nebulizer treatments for respiratory conditions such as severe asthma, cystic fibrosis, and other conditions requiring inhaled medication at home.

5INFUSOL (perfusion, nutrition, insulinothérapie)
CategoryHome infusion and nutrition therapy
Description

Dedicated home healthcare division created in 2019 to provide perfusion, nutrition, and insulinotherapy services, extending France Oxygène's home care coverage beyond respiratory assistance.

6VIVITRAVEL
CategoryPatient travel support
Description

Travel solution program enabling respiratory assistance patients to travel or relocate freely across France and Europe while maintaining continuous respiratory therapy, coordinated via the SOL Group network.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2000-01-01
Description

France Oxygène joined SOL Group, the 3rd largest European gas provider, in 2000. This integration facilitated patient care across France and Europe, enabling patients traveling or relocating to receive continued respiratory assistance through the group's network.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnerships with liberal prescribers, hospital physicians, and sleep laboratories who prescribe and refer patients requiring home respiratory assistance to France Oxygène.

3French National Health Insurance (Assurance Maladie)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with the French national health insurance system for reimbursement of home healthcare services under regulated healthcare coverage.

franceoxygene.fr
Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

VitalAire is the home healthcare arm of Air Liquide, France's largest industrial gas group, and the leading national PSAD for home oxygen, ventilation, and CPAP — directly competing with France Oxygène across the same therapy categories and prescriber base.

TypeDirect peer
Description

Orkyn' (formerly Agir à Dom) is one of France's largest PSADs providing home respiratory assistance, perfusion, and nutrition services — a direct competitor with national coverage and a similarly diversified service portfolio.

TypeDirect peer
Description

SOS Oxygène is a French home respiratory assistance provider offering oxygen therapy, ventilation, and CPAP across multiple regions — directly comparable to France Oxygène in scope, services, and target patient population.

TypeDirect peer
Description

ADEP Assistance is a French home healthcare services provider focused on respiratory assistance, perfusion, and insulinotherapy — competing directly with France Oxygène's core and INFUSOL offerings.

TypeDirect peer
Description

Bastide Le Confort Médical is a French-listed provider of home medical equipment and respiratory services — a direct peer in oxygen therapy, ventilation, and CPAP provision with national distribution.

TypeDirect peer
Description

LVL Médical is a French PSAD specializing in home oxygen therapy and respiratory assistance — a direct regional and national competitor in the same prescription-driven service model.

TypeBroad incumbent
Description

Air Liquide Healthcare is the global medical gas and home healthcare division of Air Liquide, operating VitalAire as its PSAD arm — a much larger incumbent competing with France Oxygène across home respiratory and broader home health services.

TypeBroad incumbent
Description

Vivisol is SOL Group's home healthcare subsidiary operating across multiple European countries — a sister entity within the same parent group as France Oxygène, providing respiratory, sleep, and home infusion services.

TypeBroad incumbent
Description

Linde Healthcare (formerly Linde Gas Therapeutics) is the global medical gas and home respiratory arm of Linde Group — a broad incumbent offering comparable home oxygen and ventilation services across Europe.

TypeOthers
Description

Resmed is a leading global manufacturer of CPAP, ventilation, and sleep apnea devices supplied to France Oxygène — an adjacent ecosystem participant and key equipment supplier rather than a direct service competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

France Oxygène

Home Healthcare / Respiratory Therapy Servicesfranceoxygene.fr

France Oxygène is a French home healthcare provider (PSAD), founded in 1996 and wholly-owned by SOL Group, delivering respiratory assistance — oxygen therapy, ventilation, CPAP, and aerosol therapy — to 75,000+ chronic patients across 12 agencies in Northern, Eastern, and Western France.

What France Oxygène does

France Oxygène is a French home healthcare provider (Prestataire de Santé à Domicile, or PSAD) that has specialized in respiratory assistance since its founding in 1996 in Nord-Pas-de-Calais. The company delivers and maintains medical equipment for oxygen therapy, invasive and non-invasive ventilation, Continuous Positive Airway Pressure (CPAP/PPC) therapy, and aerosol therapy for patients at home, in hospitalization-at-home (HAD) settings, in nursing homes (EHPAD), and at vacation locations. Patients are predominantly individuals with chronic respiratory insufficiency — including COPD, sleep apnea, cystic fibrosis, severe asthma, emphysema, and facial vascular algias — referred by liberal physicians, hospital pulmonologists, and sleep laboratories. The company operates 12 regional agencies across Hauts-de-France, Grand-Est, Normandie, and Bourgogne-Franche-Comté, and is a wholly-owned subsidiary of SOL Group, the 3rd largest European gas provider, which it joined in 2000 to enable cross-border patient continuity.

The core technology stack is medical-device-centric rather than software-centric: France Oxygène deploys, maintains, and monitors respiratory equipment manufactured by Resmed, Philips Respironics, Lowenstein, GCE, Caire, Devilbiss, Breas, and Inogen. The company runs a prescriber portal (Espace Médecin / medecin.franceoxygene.fr) for healthcare-professional coordination, and in 2019 extended its platform with INFUSOL — a dedicated department for perfusion, nutrition, and insulinotherapy — and a VIVITRAVEL service that coordinates respiratory care across Europe through the SOL Group network. Cap'Air adapted physical-activity centers (Coudekerque-Branche and Lens) provide adjunct lifestyle programming for respiratory-insufficiency patients. France Oxygène and InfuSol obtained ISO 9001 certification in 2023.

The business model is a regulated, reimbursement-driven home healthcare service. As a licensed PSAD, France Oxygène is reimbursed by the French Assurance Maladie national health insurance system based on physician prescriptions, with supplementary insurers covering residual amounts; the company manages all administrative procedures on behalf of patients. Revenue is effectively recurring while a patient remains on therapy, with equipment installation, maintenance, consumables, therapeutic education, and 24/7 follow-up bundled into the per-patient tariff. The customer segments are individual chronic patients on the demand side and the national payer plus the prescriber channel on the supply side, creating a B2C/B2B2C GTM anchored on referral-driven acquisition and regulated reimbursement economics rather than direct-to-consumer marketing.

France Oxygène firmographics

Firmographics
Name
France Oxygène
Legal name
FRANCE OXYGENE REGION NORD
Website
https://franceoxygene.fr
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
101–250 employees
Short description
France Oxygène is a French home healthcare provider (PSAD), founded in 1996 and wholly-owned by SOL Group, delivering respiratory assistance — oxygen therapy, ventilation, CPAP, and aerosol therapy — to 75,000+ chronic patients across 12 agencies in Northern, Eastern, and Western France.
Ownership category
akta.pro rank

France Oxygène industry classification

Industry
Product category
Home Healthcare / Respiratory Therapy Services
SIC
Services-Home Health Care Services (8082), Services-Health Services (8000)
akta.pro primary industry
Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)
akta.pro secondary industries
Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD), Home Respiratory & Ventilator Care (Skilled) (HLADAFAI), Cardiac & Pulmonary Clinical Home Health (e.g., CHF/COPD) (HSABACAI)

Keywords

  • Home respiratory assistance
  • Oxygen therapy services
  • Home healthcare provider
  • Sleep apnea treatment
  • Ventilation therapy

Where France Oxygène is headquartered

Location

Headquarters

HQ city
Templemars
HQ country
France
HQ region
Europe

Offices12 records

Markets served

France Oxygène business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Healthcare Reimbursement: As a French PSAD (Prestataire de Santé à Domicile), France Oxygène operates under the French national health insurance system. Services are reimbursed through the Assurance Maladie system based on prescriptions from physicians. The company manages all administrative procedures with health insurance funds and supplementary insurers.
  2. Home Respiratory Assistance: Core revenue stream from providing oxygen therapy, ventilation (invasive and non-invasive), CPAP, and aerosol therapy to patients at home, in nursing homes, or during hospitalization at home.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

France Oxygène product offering

Product offering

Core offering

France Oxygène is a French home healthcare provider (Prestataire de Santé à Domicile, PSAD) that installs, maintains, and supports respiratory assistance equipment for patients at home. Its core services cover home oxygen therapy, invasive and non-invasive ventilation, Continuous Positive Airway Pressure (CPAP) for sleep apnea, and aerosol therapy, delivered 24/7 through 12 regional agencies across Northern, Eastern, and Western France under the French national health insurance reimbursement system.

Product overview

France Oxygène is a Prestataire de Santé à Domicile (PSAD) offering a comprehensive home healthcare platform centered on respiratory assistance. The core offering combines oxygen therapy, invasive and non-invasive ventilation, CPAP therapy, and aerosol therapy, supported by medical equipment provision from major manufacturers. The company has expanded through INFUSOL (perfusion/nutrition/insulinotherapy, 2019) and VIVITRAVEL (travel assistance), while Cap'Air centers provide adapted physical activity programs. The prescriber portal (Espace Médecin) enables healthcare professional coordination, all supported by 24/7 service and ISO 9001 certification.

Differentiator

Problem solved

Functional benefit

Brands

  • Cap'Air: Club d'Activité Physique Adaptée pour Insuffisants Respiratoires - adapted physical activity centers for respiratory insufficiency patients, located in Coudekerque-Branche and Lens, Hauts-de-France.
  • VIVITRAVEL

Products and services

  • Oxygénothérapie à domicile (Home oxygen therapy) Home oxygen therapy service providing supplemental oxygen for patients with respiratory conditions such as COPD, emphysema, cystic fibrosis, and severe asthma who require oxygen support at home. The service includes equipment delivery, installation, and ongoing maintenance.
  • Ventilation invasive et non invasive (Invasive and non-invasive ventilation) Respiratory ventilation services covering both invasive and non-invasive ventilation methods for patients requiring breathing assistance at home, including trachéotomie (tracheostomy) support.
  • Pression Positive Continue (CPAP) therapy Continuous Positive Airway Pressure (CPAP) therapy for sleep apnea in adults, children, and central apnea cases, including device provision, installation, follow-up, and therapeutic education.
  • Aérosolthérapie (Aerosol therapy) Aerosol therapy service providing nebulizer treatments for respiratory conditions such as severe asthma, cystic fibrosis, and other conditions requiring inhaled medication at home.
  • INFUSOL (perfusion, nutrition, insulinothérapie) Dedicated home healthcare division created in 2019 to provide perfusion, nutrition, and insulinotherapy services, extending France Oxygène's home care coverage beyond respiratory assistance.
  • VIVITRAVEL Travel solution program enabling respiratory assistance patients to travel or relocate freely across France and Europe while maintaining continuous respiratory therapy, coordinated via the SOL Group network.

Quantifiable outcome

  • 75,000+ patients cared for at home, in HAD, in EHPAD, and at vacation locations

Companies that use France Oxygène

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles2 records

France Oxygène technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

France Oxygène partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • SOL GroupcoreStrategic or Co-development Partner · 1 January 2000France Oxygène joined SOL Group, the 3rd largest European gas provider, in 2000. This integration facilitated patient care across France and Europe, enabling patients traveling or relocating to receive continued respiratory assistance through the group's network.
  • Sleep Laboratories and HospitalscoreChannel Partner/ Reseller/ DistributorPartnerships with liberal prescribers, hospital physicians, and sleep laboratories who prescribe and refer patients requiring home respiratory assistance to France Oxygène.
  • French National Health Insurance (Assurance Maladie)coreStrategic or Co-development PartnerCollaboration with the French national health insurance system for reimbursement of home healthcare services under regulated healthcare coverage.

Scale indicators4 records

Recent moves11 records

Expansion highlights4 records

France Oxygène competitors and assessment

Company assessment

Direct peers

  • VitalAire (Air Liquide Healthcare): VitalAire is the home healthcare arm of Air Liquide, France's largest industrial gas group, and the leading national PSAD for home oxygen, ventilation, and CPAP — directly competing with France Oxygène across the same therapy categories and prescriber base.
  • Orkyn' (Agir à Dom): Orkyn' (formerly Agir à Dom) is one of France's largest PSADs providing home respiratory assistance, perfusion, and nutrition services — a direct competitor with national coverage and a similarly diversified service portfolio.
  • SOS Oxygène: SOS Oxygène is a French home respiratory assistance provider offering oxygen therapy, ventilation, and CPAP across multiple regions — directly comparable to France Oxygène in scope, services, and target patient population.
  • ADEP Assistance: ADEP Assistance is a French home healthcare services provider focused on respiratory assistance, perfusion, and insulinotherapy — competing directly with France Oxygène's core and INFUSOL offerings.
  • Bastide Le Confort Médical: Bastide Le Confort Médical is a French-listed provider of home medical equipment and respiratory services — a direct peer in oxygen therapy, ventilation, and CPAP provision with national distribution.
  • LVL Médical: LVL Médical is a French PSAD specializing in home oxygen therapy and respiratory assistance — a direct regional and national competitor in the same prescription-driven service model.

Broad incumbents

  • Air Liquide Healthcare: Air Liquide Healthcare is the global medical gas and home healthcare division of Air Liquide, operating VitalAire as its PSAD arm — a much larger incumbent competing with France Oxygène across home respiratory and broader home health services.
  • Vivisol (SOL Group): Vivisol is SOL Group's home healthcare subsidiary operating across multiple European countries — a sister entity within the same parent group as France Oxygène, providing respiratory, sleep, and home infusion services.
  • Linde Healthcare: Linde Healthcare (formerly Linde Gas Therapeutics) is the global medical gas and home respiratory arm of Linde Group — a broad incumbent offering comparable home oxygen and ventilation services across Europe.

Others

  • Resmed: Resmed is a leading global manufacturer of CPAP, ventilation, and sleep apnea devices supplied to France Oxygène — an adjacent ecosystem participant and key equipment supplier rather than a direct service competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

France Oxygène social profiles

Digital presence

France Oxygène compliance and trust

Trust signal

Compliance1 record

France Oxygène financial estimates

Financial estimate

Revenue estimate

Valuation estimate

France Oxygène leadership team

Management profile

Number of profiles

Profiles2 records

France Oxygène funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

France Oxygène M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about France Oxygène

What does France Oxygène do?

France Oxygène is a French home healthcare provider (Prestataire de Santé à Domicile, PSAD) that installs, maintains, and supports respiratory assistance equipment for patients at home. Its core services cover home oxygen therapy, invasive and non-invasive ventilation, Continuous Positive Airway Pressure (CPAP) for sleep apnea, and aerosol therapy, delivered 24/7 through 12 regional agencies across Northern, Eastern, and Western France under the French national health insurance reimbursement system.

Is France Oxygène a public or private company?

France Oxygène is a private company. It is classified as corporate owned and is currently operating.

When was France Oxygène founded?

France Oxygène was founded in 1996. It employs 101 to 250 people.

Where is France Oxygène based?

France Oxygène is headquartered in Templemars, France, in the Europe region.

How does France Oxygène make money?

Two revenue lines are on record. Healthcare Reimbursement is the primary driver. The others are home Respiratory Assistance.

Who are France Oxygène's main competitors?

Direct peers on record are VitalAire (Air Liquide Healthcare), Orkyn' (Agir à Dom), SOS Oxygène, ADEP Assistance, Bastide Le Confort Médical and LVL Médical. Broad incumbents are Air Liquide Healthcare, Vivisol (SOL Group) and Linde Healthcare. Resmed is listed as an others.

Does France Oxygène have an API?

No public API is recorded for France Oxygène.

What industry is France Oxygène in?

France Oxygène's product category is Home Healthcare / Respiratory Therapy Services. Its primary akta.pro industry code is HLAKANAM, Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management, with a secondary code of HSABAKAD, Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers). Its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales